Cipla trades flat following South African regulators nod for HIV drug

In the future, TLD will be manufactured at Ciplas facilities in Durban and Uganda, reinforcing Ciplas commitment to produce medicines in Africa for Africa and ensuring more affordable treatment for patients.

from India Infoline News Service https://ift.tt/2x6unfs